Subcutaneous ketorolac--a new development in pain control.

@article{Blackwell1993SubcutaneousKN,
  title={Subcutaneous ketorolac--a new development in pain control.},
  author={Nm Blackwell and L Bangham and Marina L. Hughes and David H. Melzack and IvanF. Trotman},
  journal={Palliative medicine},
  year={1993},
  volume={7 1},
  pages={
          63-5
        }
}
Pain due to advanced malignant disease does not always respond to opioids, or the possible use of opioids may be limited by the occurrence of adverse effects. This paper describes the successful use of ketorolac, a new nonsteroidal anti-inflammatory drug, given by continuous subcutaneous infusion. Seven patients with pain due to advanced malignant disease taking opioid analgesia were considered to have inadequate symptom control because of opioid unresponsiveness (n = 1), opioid-related adverse… CONTINUE READING